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The precise mechanisms and fine regulation of antigen-driven B cell activation and 
differentiation  must  surely  depend  on  several  cell  surface  molecular  systems  in 
addition  to  immunoglobulin.  One  way  to  investigate  the  reception  of regulatory 
signals by B cells, and the responses that ensue, is to use antibodies to immunogenet- 
ically defined  components of the B  cell surface as probes  to perturb  one or another 
feature of B cell responses to various antigens, and thereby infer a particular function 
for each component. 
The  components  of most  evident  interest,  clearly,  are  those  whose  expression  is 
limited to B cells, or to B cells and collaborating cells. In the former category is Lyb- 
2, an early B cell surface feature lacking on the terminal plaque-forming cells (PFC) 1 
(1),  which  we  have  shown  to  be  involved  at  the  time  of B  cell  triggering  by  T- 
dependent  (TD)  antigen  (2,  3).  The  Ly-5 system  (4)  belongs  to the  latter  category, 
since one or another form of this Ly-5 molecular family (5)  is expressed by T  cells and 
macrophages (Mq~) as well as by other hematopoietic cell lineages  (6-8). The studies 
described  in  the  present  report  signify a  distinctive  role  for Ly-5 in  B  cell  function 
that differs from that of Lyb-2. 
Materials and Methods 
Mice.  Mice 8-14 wk of age were obtained from colonies at  Sloan-Kettering Institute  for 
Cancer Research, except for C57BL/6 (B6) and DBA/2 (purchased from The Jackson Labo- 
ratory, Bar Harbor, ME). 
Antigens.  Sheep erythrocytes (SRBC) were purchased from Gibco Diagnostics Laboratories, 
Madison,  WI. Trinitrophenylated  Ficoll  (TNP-F) was prepared  as described by Inman  (9). 
Aminoethylcarboxymethyll00-F (Biosearcb, San Rafael, CA) was conjugated with 2,4,6-trinitro- 
benzenesulfonic acid (Eastman Kodak Co., Rochester, NY) in 0.2 M borate buffer, pH 9.2, at 
room temperature for 2 h and then dialyzed extensively against phosphate-buffered saline.  This 
preparation contained 36 TNP groups per 400,000 daltons of F. TNP-Brucella abortus  (TNP-BA) 
was prepared as described  (10) using BA ring test antigens (U. S. Department of Agriculture, 
Ames, IA). TNP-lipopolysaccharide (TNP-LPS) was prepared as described (11) using LPS from 
Escherichia coil 0111 :B4 (Difco Laboratories, Detroit, MI). 
* Supported in part by grants CA-22131 and AI-00329 from the National Institutes of Health. 
:~ American Cancer Society Research Professor of Cell Surface Immunogenetics. 
1 Abbreviations used in this paper: a, anti; BA, Brucella abortus; C, complement; F, Ficoll; LPS, lipopolysac- 
charide; me, monoclonal; M~, macrophage; MLC, mixed lymphocyte culture; PFC, plaque-forming cells; 
SN, supernatant;  SRBC, sheep erythrocytes; TD, thymus-dependent; TI-I and TI-2, thymus-independent 
(antigens) types 1 and 2; TNP, trinitrophenyl. 
J. ExP. MED. © The Rockefeller  University Press • 0022-1007/83/04/1077/1251.00  10 7 7 
Volume 157  April 1983  1077-1088 1078  Ly-5 IN B CELL  REGULATION 
Monoclonal (me) Alloantibodies.  All studies were done with the mc Ly-5 alloantibodies (ascites 
plus serum)  anti-Ly-5.1 (clone  104-2) and anti-Ly-5.2 (clone A-20)  (12).  Both  are yz,~¢ and 
critically distinguish the B6 and B6-Ly-5.2 congenic strains. Both react with adherent accessory, 
T, and B cells in protein A binding and direct immunofiuorescence assays. The Lyb-2.1  me 
antibody was the same as used in previous studies (1  3). 
Cell Preparations 
T CELLS.  These were prepared by nylon selection of spleen cells (13). 
T-DEPLETED SPLEEN CELLS.  T  cells were eliminated by exposure of spleen cells first to mc- 
a-Thy-1.2 (1:100) plus rabbit serum complement (C) and then to [mc-a-Lyt-1.2 (1:25) and mc- 
a-Lyt-2.2 (1:25)] plus C as described (3). The two treatments were required to eliminate residual 
T cells effectively  (3). 
M4~.  Splenic adherent cells treated with mc-a-Thy-l.2 plus C  and irradiated with  1,500 
rad were used as MS (3). 
Mdp-DEPLETEO CELLS.  Spleen cells (~18 ×  107) were passed  over a Sephadex G-10 column 
(bed volume, 30 ml; Pharmacia Fine Chemicals, Dip. of Pharmacia Inc., Piscataway, N  J) and 
eluted with 25 ml of RPMI 1640 (Grand Island Biological  Co., Grand Island, NY) containing 
20%  fetal  bovine serum  (FBS)  and antibiotics (14), and the  procedure was  repeated.  This 
treatment reduced the a-SRBC PFC response by >95% and esterase-positive cells from 5-9% 
to <0.5%, without significant disproportion ofT and B cells, determined by immunofluorescence 
with fluorescein-conjugated mc-a-Thy-1.2 and rabbit a-mouse immunoglobulin. 
B CELLS.  M~-depleted spleen cells were treated as above for elimination ofT cells. 
Mishell-Dutton Culture.  Spleen cells, untreated or as combinations  of fractionated cell popu- 
lations (see above), were cultured in RPMI 1640 supplemented with 10% FBS, L-glutamine (2 
mM), 2-mercaptoethanol (5 X 10  -° M), sodium pyruvate (1 mM), streptomycin (100 #g/ml), 
penicillin (100  U/ml), and  Hepes  buffer  (10  raM)  in  16-ram  flat-bottomed Linbro plates 
(Linbro Chemical Co., Hamden, CT) with SRBC (5 X 106), TNP-BA (1:1,000 of stock), TNP- 
LPS  (1  /~g/ml),  or  TNP-F  (1  ng/ml),  unless otherwise  stated,  at  37°C  in  a  humidified 
atmosphere of 10% CO2 and 90% air without rocking. Cultures were fed daily as in (2). 
PFC Assay.  PFC counts were determined on day 5 for a-SRBC, and on day 4 for a-TNP 
responses  to T-independent (TI)  antigens, by the  slide version (15) of Jerne plaque assay. 
Lightly conjugated TNP-SRBC was prepared as described (16). Results were expressed as mean 
PFC  per  culture  ---  SEM  or  as  a  percentage of the  standard control  response  [100  (PFC 
experiment)/(PFC control)]. 
Preparation of Factors 
MIXED LYMPHOCYTE CULTURE SUPERNATANT (MLC-SN),  5  X  10  6 B6 spleen cells were stimulated 
with 5  ×  106 irradiated DBA/2 spleen cells  (2,000 rad)  in  1 ml of Mishell-Dutton medium 
(MDM) in a Linbro well. 24 h later, the SN was centrifuged, filtrated, and stored at -20°C. 
Higher concentrations  of this preparation had significant M~-substituting  activity as previously 
reported (3). 
M~-SN.  2 ×  106 P388D.1  cells, kindly provided by Dr. Peter Ralph of the Sloan-Kettering 
Institute for Cancer Research, were cultured in 1 ml of MDM with 10 ng/ml phorbol myristate 
acetate (Sigma Chemical Co., St.  Louis, MO) in a Linbro well for 4 d. The cell-free  SN was 
dialyzed against 100 vol of RPMI  1640, filtrated, and stored at -20°C. This preparation, at 
concentrations used in this study (0.1-4%),  had negligible capacity to replace T cell activity in 
supporting a-SRBC PFC generation from T-depleted cells. 
Results 
Inhibition of Generation of a-SRBC PFC by mc Ly-5 Alloantibod  7  (Fig.  1).  Spleen cells 
from  B6  (Ly-5.1)  and  congenic B6-Ly-5.2  mice  were  cultured with  SRBC  in  the 
presence of various concentrations of mc-a-Ly-5.1 for 5 d. Fig.  1 shows that mc-a-Ly- 
5.1  antibody  at  concentrations of  from  1:100  to  1:1,600  inhibited a-SRBC  PFC 
generation from  B6 cells by  75-83%.  Specificity for  Ly-5 is shown by the  fact  that 
same antibody caused no significant reduction in the responses from congenic B6-Ly- YAKURA,  SHEN,  BOURCET,  AND  BOYSE 
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Fie.  1.  Inhibition of generation of ¢~-SRBC PFC by Ly-5 mc alloantibody. 5 x  108 B6 or B6-Ly- 
5.2 (control) spleen cells were cultured with 5 ×  l0  s SRBC in the presence ofmc-a-Ly-5.1 throughout 
the 5-d culture period. Control responses (without antibody) were 5,825 ±  235  for B6, and 3,952 
+  125 for B6-Ly-5.2 (standard 100% response for calculation of percent PFC response). 
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TABLE  I 
The Reduction of a-SRBC PFC Generation by Ly-5 Antibody Is Due To Its Reaction with Non-T Cells 
Composition of culture  Percent response:l: 
with mc-ot-Ly-5.1  Control PFC re- 
Experi-  T-depleted cells*  T  cells*  sponse (no anti- 
ment 
1:400  1:800  body) 
Strain  Number  Strain  Number 
X  10  -6  X  10  -6 
B6  4  B6  1  35  NT§  6,065 +  790 
B6-Ly-5.2  4  B6-Ly-5.2  1  114  NT  2,547  +  259 
B6  4  B6-Ly-5.2  1  38  NT  6,125 +  503 
B6  4  B6-Ly-5.2  0.5  48  NT  2,853 ±  569 
B6-Ly-5.2  4  B6  1  85  NT  5,766 ±  419 
B6-Ly-5.2  4  B6  0.5  88  NT  5,746 +  122 
B6  5  B6-Ly-5.2  2  29  30  12,037 +  706 
B6  5  B6-Ly-5.2  1  33  35  9,709 +  395 
B6-Ly-5.2  5  B6  2  94  97  3,71 l  +  198 
B6-Ly-5.2  5  B6  1  93  99  3,951  +  676 
* Responses of T-depleted cells alone, and of T  cells alone, were nil. 
100 (response with antibody)/(response without antibody). 
§ Not tested. 
5.2  cells  (Fig.  1).  The  same  results  (not  shown)  were  obtained  with  mc-a-Ly-5.2 
antibody,  with  specificity for B6-Ly-5.2  congenic  spleen cells. 
Target Cells Affected by Ly-5 Antibody (Tables I and II).  Ly-5 is expressed  by most  or 1080  Ly-5 IN  B CELL REGULATION 
TABLE  II 
The Reduction of PFC Generation by Ly-5 Antibody Is Due  To Its Reaction with B Cells rather than M~ 
Percent 
Composition of culture  response 
with mc-  Control PFC re-  Experi-  ~-Ly-5.1 
ment  M~-depleted  cells*  M4~*  sponse (no antibody) 
Strain  Number  Strain  Number  1:500 
× 10  .6  × 10 4 
B6  4  B6  8  32  5,147 +_ 179 
B6-Ly-5.2  4  B6-Ly-5.2  8  98  6,929 +_ 987 
B6  4  B6-Ly-5.2  8  24  10,321 ___ 1166 
B6  4  B6-Ly-5.2  4  38  2,840 + 50 
B6-Ly-5.2  4  B6  8  96  3,711 + 66 
B6-Ly-5.2  4  B6  4  96  1,982 + 90 
B6  5  B6-Ly-5.2  8  38  17,211 + 959 
B6  5  B6-Ly-5.2  4  40  10,095 +  1100 
B6-Ly-5.2  5  B6  8  120  12,662 + 376 
B6-Ly-5.2  5  B6  4  140  6,012 + 470 
* Responses of M~-depleted cells alone: B6, 133 --- 24 (experiment 1) and 380 -- 84 (experiment 2); B6-Ly- 
5.2, 93 -+ 27 (experiment t) and 281 +- 28 (experiment 2). Responses of Mq5 alone were all nil. 
all hematopoietic cell types. To determine whether T  and non-T cells are involved in 
the reduction of a-SRBC PFC generation by Ly-5 antibody (above), spleen cells from 
B6 and B6-Ly-5.2 mice were fractionated into T  and T-depleted populations, com- 
bined in all four possible combinations, and cultured with or without mc-a-Ly-5.1 at 
concentrations of 1:400 and 1:800. As shown in Table I, a-SRBC PFC generation was 
reduced only when the T-depleted population (B and accessory cells) was Ly-5.1 ; the 
Ly-5 type of the T  population was  irrelevant. This implies that  the  action of Ly-5 
antibody in reducing PFC generation is on B or accessory cells rather than T  cells. A 
similar fourfold combination was then used to determine whether the PFC-reducing 
effect  of Ly-5 antibody is due to its reaction with B  cells or with Mq~. The two cell 
donors, as before, were B6 and B6-Ly-5.2, the cell populations in this case being M~ 
depleted and M~ selected. Table II shows that PFC responses were reduced only when 
the phenotype of the M@depleted cells was Ly-5.1, corresponding to the antibody; 
the phenotype of the M~ was irrelevant. This implies that the cells mostly concerned 
in PFC reduction by Ly-5 antibody are B cells. 
Evidence against Suppression or a  Shift of Kinetics  (Table III,  Fig.  2).  To test whether 
the  PFC  inhibitory property  of Ly-5  antibody might  be  due  to  indirect or  direct 
activation  of  suppressor  cells,  two  sets  of  experiments  were  performed.  The  first 
experiments tested the possibility that  the interaction of B  cells with Ly-5 antibody 
induces Lyt-2  ÷ suppressor cells. Nylon-selected splenic T  cells were treated with Lyt- 
2 antibody and C  under predetermined optimal conditions for elimination of Lyt-2  ÷ 
cells (removing the Lyt-123 and Lyt-23 cell sets), and were then added to T-depleted 
spleen  cells.  This  pre-elimination of Lyt-2  +  cells  did  not  affect  the  PFC-reducing 
capacity of Ly-5 antibody (Table III). 
In the  second set  of experiments, unselected spleen cells  from  B6  and B6-Ly-5.2 
donors were combined in serial proportions and cultured with mc-a-Ly-5.1 (1:800) or YAKURA, SHEN,  BOURCET,  AND  BOYSE 
TABLE  III 
Lyt-2 + Cells Are Not Involved in Reduction of PFC Generation 
Caused by Ly-5 Antibody 
Percent PFC response  Spleen celt donor  T  cells added*  with: 
B6  mc-a-Ly-5.1 (l: 1,000) 
Unselected  31 
Lyt- 1  35 
B6-Ly-5.2  mc-ct-Ly-5.2 ( 1  ! 1,000) 
Unselected  40 
Lyt- I  34 
* Nylon-purified T  cells were  treated  either  with  normal mouse serum  (for 
unselected cells) or with mc-a-Lyt-2.2 antibody (for Lyt-t cells) plus C.  1 × 
106 unselected cells, or  1 ×  106 selected Lyt-1 cells, were added to 4  ×  l0  s 
syngeneic T-depleted cells. 
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FIc.  2.  Evidence  against  suppression.  B6  and  B6-Ly-5.2  spleen  cells  were  combined  in  the 
proportions indicated and cultured with SRBC in the presence of mc-a-Ly-5.1 (0,  1:800)  or mc-a- 
Ly-5.2 ((3,  1:400). 
mc-a-Ly-5.2 (1:400). Fig.  2 shows a  virtually linear relationship between the degree 
of PFC reduction and the proportion of ceils of Ly-5 type corresponding to the Ly-5 
antibody. These data are not compatible with any evident model of suppression. The 
second set of experiments is valuable in excluding possible suppression by non-T cells 
(B cells or M#). 
In the other experiments it was observed that the peak time of PFC generation was 
same in the presence or absence of Ly-5 antibody, signifying that  the lower peak in 
the  presence  of antibody  is  not  due  to  delay  or  acceleration  in  the  rate  of PFC 
generation. 
Effect of Ly-5 Antibody  on PFC Generation to  TI Antigens  of Types  1 and 2  (Table IV and 
Fig.  3).  Table IV  shows  that  Ly-5 antibody,  at  concentrations causing maximal 
reduction of a-SRBC  PFC  generation, did not demonstrably inhibit  generation of 
PFC to the two TI-1 antigens tested, TNP-BA and TNP-LPS. This was equally true 1082  Ly-5  IN  B  CELL  REGULATION 
TABLE IV 
Effect of Ly-5 Antibody on Responses to TI-I Antzgens 
Percent  PFC 
Antigen  Spleen cell donor  Antibody concentration  response* 
TNP-BA  B6  mc-a-Ly-5.1  1:100  153 +  3 
(l: 103:~)  1:200  120 +_ 6 
1:400  88 +  1 
1:800  92 +  9 
B6-Ly-5.2  mc-a-Ly-5.2  1:100  123 +  3 
1:200  97 -  14 
1:400  103 +  19 
1:800  113 +  19 
TNP-LPS  DBA/2  mc-a-Ly-5.1  1  : 100  82 +  14 
(1 /tg/mt:~)  1:400  88 "+ 15 
1  : 1,600  94 +  8 
* Mean PFC responses (+ SEM) of two with TNP-BA and five experiments with TNP-LPS. 
The full range of antigen concentrations tested, with results that were the same as those illustrated in this 
Table, were 10  -3 to 10 -6 dilutions of stock for TNP-BA and 0.1  to 100/tg/m[ for TNP-LPS (see text). 
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1/dilution  (x 10  -2) 
B  (DBA/2 cells) 
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1021011001(31102103104 
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FIc.  3.  Inhibition of PFC response to TNP-F by Ly-5 antibody. (A) Effect of antibody concentra- 
tion.  10 ×  106 B6, DBA/2 (Ly-5.1),  or B6-Ly-5.2  congenic (control) spleen cells were cultured with 
TNP-F (1  ng/ml) in the presence of the concentrations of mc-a-Ly-5. I indicated for 4 d.  (B) Effect 
of antigen concentration.  10 X  106 DBA/2 spleen cells were cultured in the presence (0) or absence 
(C)) of mc-a-Ly-5.1  (1:100)  with the range of TNP-F antigen concentrations indicated. 
for antigen concentrations ranging from 0.1  to  100 #g/ml for TNP-LPS and for 10  -a 
to  10  -6 dilutions of stock for TNP-BA (data not shown). 
The prototype TI-2 antigen tested, TNP-F, gave a  quite different result. This mc- 
a-Ly-5.1 antibody in concentrations >1:1,600  gave strong Ly-5-specific inhibition  of 
a-TNP PFC  (Fig.  3,  panel A), and this inhibition  was evident with TNP-F antigen 
concentrations ranging from 102 to 10  -4/lg/ml (panel B). The degree of inhibition of 
a-TNP PFC was similar to that of a-SRBC PFC, roughly 60-80% reduction.  DBA/2 
was included in these studies as a  high responder to the antigens used. 
Time of Action of Ly-5 Antibody (Fig.  4).  Fig. 4 shows that Ly-5 antibody added >24 
h  after initiation  of culture  is  relatively ineffective in  reducing  PFC  generation  to 
SRBC and TNP-F, and antibody addition delayed for >48 h  has virtually no effect. 100 
g 
Q. 
g- 
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B6-Ly-5.2 
-----  4-~\  /  - --  ~.~°  =  =  =~  o  ¢  ~  loo  50 
B6 
I  I  I  I  I  I  I  L 
0  1  2  3  0  1  2  3 
Time  of  addition  of mc-a-Ly-5.1  (day) 
Ftc.  4.  Effects of Ly-5 antibody added at increasing intervals after initiation of culture. (A) SRBC 
responses, mc-0t-Ly-5.1  (1:100)  was added  to  B6 or  B6-Ly-5.2  spleen  cell  cultures  at  the  times 
indicated.  (B)  TNP-F  responses,  mc-a-Ly-5.l  (1:100)  was  added  to  DBA/2  (Ly-5.1)  spleen cell 
cultures at the times indicated. 
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TABLE  V 
Generation of PFC  from (B6 × B6-Ly-5.2)F1 Cells in the 
Presence of Ly-5 Antibody 
Antigen 
Percent response* with mc-a-Ly-5.1 
1  : 100  1:400 
SRBC  139 ±  14  112 +  2 
TNP-F  78 ±  10  84 ±  11 
* Mean (+SEM) of four separate experiments. 
In view of the persistent expression of Ly-5 on mature B cells, these data imply that 
Ly-5 is involved in an early phase of B cell activation that is complete within 2 d. 
Generation of PFC from  Ly-5 Heterozygous Cells  in  the  Presence of Ly-5 Antibody  (Table 
V).  The purpose of this test was to find whether Ly-5 antibody might suppress PFC 
generation by direct effect upon B cells rather than by obstructing function of the Ly- 
5  molecule.  In  the  case  of the  Lyb-7  system,  antibody  similarly  suppresses  PFC 
generation to the TI-2 antigen TNP-F, and this suppression affects Lyb-7 heterozy- 
gotes as well as homozygotes, which would allow the former interpretation  (17).  This 
is not so with Ly-5. Thus mc-a-Ly-5.1 antibody caused no reduction in PFC generation 
from Ly-5 heterozygous cells with TNP-F or SRBC  (Table V). 
Effect  of Ly-5 Antibody on a-SRBC PFC Generation Assisted by  T and Mob Factors (Table 
VI and Figs.  5,  6,  and 7).  Generation of PFC  to SRBC  and  to TNP-F depends on 
both T  cells and M(h (18-21).  The question arises whether Ly-5 is involved in the B 
cell response to T  or M(h signals. The rationale of the following experiments is that if 
Ly-5 is concerned in the interaction of B cells with T  cells or M(h, then PFC reduction 
by Ly-5 antibody should be competitively overcome by T  or Mq~ helper factors. 
RESPONSES OF T-DEPLETED CELLS ASSISTED BY MLC-SN.  Table VI illustrates that Ly- 
5 antibody caused maximal a-SRBC PFC reduction in concentrations of MLC-SN as 
high as 40%.  Even in 80% MLC-SN, reduction was only slightly less,  and this small 
effect  could  well  be  due  to  minor  contamination  of  MLC-SN  with  M(h  factor. 1084  Ly-5  IN  B  CELL REGULATION 
TABLE  VI 
Reduction of a-SRBC PFC Generation  fiom  T-depleted Cells by Ly-5 and 
Lyb-2 Antibodies in the Presence  of MLC-SN* 
Concentration  Percent response with  Control response (no an- 
of MLC-SN  mc-a-Ly-5. I  mc-a-Lyb-  2.1  tibody) 
% 
I0  35  32  1,284 ±  153 
20  25  29  7,043 ±  521 
40  30  18  23,129 ±  5285 
80  50  5  116,615 ±  19041 
* One of three similar experiments is shown. 5 X 106 T-depleted cells from B6- 
Lyb-2.1 mice were cultured with SRBC and serial concentrations of MLC- 
SN in the presence  of mc-a-Ly-5, l  (1:100) or mc-a-Lyb-2.1  (l:50). a-SRBC 
PFC were assayed on day 5. 
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Evidently  MLC-SN  does  not  competitively  inhibit  the  action  of Ly-5  antibody.  In 
parallel  tests with mc Lyb-2  antibody,  to  represent  a  system  known  to be concerned 
in  early  B  cell  activation  and  evidently  not  through  the  T  cell  interaction  process, 
MLC-SN  did not competitively inhibit the action of Lyb-2 antibody in reducing PFC 
generation either  (Table VI). 
RESPONSES OF MO-DEPLETED CELLS ASSISTED  BY M~-SN  (FIG.  5).  To test  whether  Ly- 
5  might be concerned in the process of B  cell interaction  with MqS,  e.g., as a  receptor 
for M4~ signals,  the effect of Ly-5 antibody was assessed  on responses of Mdp-depleted 
cells (composed of T  and B  cells) assisted by 0.5-4% M0-SN.  If Ly-5 is involved in the 
process of M4~ signal  reception,  MO-SN should  compete with  Ly-5 antibody  at some 
Fie.  5.  With  M~k-depleted cells, M~-SN competitively inhibits PFC reduction by Ly-5 but  not 
Lyb-2 antibody. 4 ×  106 M4)-depleted cells from B6-Lyb-2.1 congenic mice were cultured with serial 
concentrations of Mq~-SN in the absence (O) or presence of mc-a-Ly-5.1  (0, 1  : 100) or mc-a-Lyb-2.1 
(A,  1:50) antibody. Representative data for one of three experiments. YAKURA,  SHEN,  BOURCET,  AND  BOYSE  1085 
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FIG.  6.  With purified B cells and MLC-SN, Mq~-SN competitively inhibits PFC reduction by Ly- 
5 but not Lyb-2 antibody. Purified B cells (4 X  10  c) from B6-Lyb-2.1 congenic mice were cultured 
with the serial concentrations of Mq~-SN shown, together with mc-a-Ly-5.1 (Q,  1:100)  or mc-0t-Lyb- 
2.1  (A,  1:50)  antibody. On day 2,  15% MLC-SN was added to provide T  helper factors, and PFC 
were  assayed on  day 5.  Mean data  from  three experiments.  Responses of B  cells plus MLC-SN 
without antibody or M~b-SN  (not shown) were <30% of control response with 0.125% Md0-SN and 
<15% of control responses with 0.25 to 4% M~ib-SN. Responses of B cells with M@SN alone, at all 
concentrations, were always <5% of controls, which included MLC-SN. 
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FIG.  7.  Coincidence of Ly-5 antibody action with timing of Mq~ factor action, in contrast to Lyb- 
2 antibody. Purified B cells (4.5 ×  10  n) from B6-Lyb-2.1 congenic mice were cultured with antigen 
for 5 d. Mq~-SN  (0.4%)  was added at the initiation of culture (panel A) or at 44 h  (panel B). MLC- 
SN  (15%)  was added  at  44  h  in  both  cases. Either  mc-a-Ly-5.1  (O,  1:100)  or mc-a-Lyb-2.1  (A, 
1:100)  was included at the times indicated. 
point. Fig. 5 shows that in fact there was a direct correlation between PFC generation 
in the presence of Ly-5 antibody (ordinate)  and concentration of MqS-SN  (abscissa). 
In contrast, PFC reduction by Lyb-2 antibody was not significantly affected by M~- 
SN through the same range of concentration. 
RESPONSES  OF  PURIFIED  B  CELLS  ASSISTED  BY  Mdp-SN  AND  MLC-SN  (FIGS.  6  AND  7). 
The following experiments confirm that Ly-5 is concerned in the interaction of B cells 
with  M~.  Purified  B  cells  from  B6-Lyb-2.1  congenic  mice  (Ly-5.1,  Lyb-2.1) were 
cultured with a  wide range of Mq~-SN  (0.125-4%)  in the presence of mc-a-Ly-5.1 or 1086  Ly-5 IN B CELL REGULATION 
mc-a-Lyb-2.1 antibody. As a  source of T  helper factors,  15% MLC-SN was added  2 
d  later. As shown in Fig. 6, Ly-5 antibody strongly inhibited PFC generation from B 
cells cultured  with  lower concentrations  of MC-SN  (0.125-0.5%),  but  this  blocking 
effect was progressively abrogated at  higher concentrations  (2-4%). Thus  the  PFC- 
reducing effect of Ly-5 antibody was reversed by overloading with  M~a-SN in dose- 
dependent  fashion.  In contrast,  Lyb-2 antibody strongly inhibited  PFC  generation 
from B cells assisted by M~-SN irrespective of MqS-SN concentrations. 
If Ly-5 is concerned in reception or operation of M~a factor, then PFC inhibition by 
Ly-5 antibody should  be maximal when antibody is added  at  the time of action of 
Mdp factor, and this is so.  When  Mdp-SN  was added to B cell cultures at the time of 
initiation,  Ly-5 antibody was effective only when added  at that  time (Fig.  7, panel 
A). When addition of M¢-SN was delayed for 44 h, Ly-5 antibody was effective when 
added  up  to  44  h  later,  but  not  thereafter  (panel  B).  The  contrast  with  Lyb-2  is 
evident in panels A and B. 
These results imply that  Ly-5 mediates a  B cell activation process that  is distinct 
from the action of Lyb-2 and that Ly-5 antibody either reacts with a molecule of high 
affinity for helper factors present  in  M~b-SN  but  not  for T  helper factors present  in 
MLC-SN, or affects this process by inactivating signals generated by the reaction of 
M~b signal with its receptor. 
Discussion 
These studies  of the immune functional  correlates of Ly-5 followed the lines that 
were adopted  for previous study of Lyb-2. Unlike  Lyb-2, expression  of Ly-5 is  not 
confined to B cells but occurs also in T  cells, M~b, and other hematopoietic lineages. 
Nevertheless the only functions we have seen to be significantly affected by inclusion 
of Ly-5 antibody in  assay of immune function  in  vitro are those associated with  B 
cells.  Since  T  cells and  Mqb have functions  other than  immunological--T cells are 
concerned  in  erythropoiesis  (22  24),  for example--Ly-5 on  non-B  cells might  have 
nonimmunological functions that have not been studied. 
In comparing the action of Lyb-2 and  Ly-5 mc antibodies  in  immune functional 
assays, the points of factual similarity are that both inhibit  the generation of PFC to 
TD antigen (SRBC) but not to TI- 1 antigen {TNP-LPS and TNP-BA), and in neither 
case can this be attributed to suppression by direct action upon the B cell or indirect 
action through other cells. A critical distinction  between the two systems is that Ly-5 
antibody inhibits PFC generation to TI-2 antigen  (TNP-F), whereas Lyb-2 antibody 
does not. The salient property of TNP-F in this connection is that with this antigen, 
like SRBC, the PFC response in vitro depends on T  cells and M~p (18-21), in contrast 
to TI-1 antigen. On these grounds Ly-5 could be involved in reception or effects ofT 
cell or Mqb signals, or alternatively Ly-5 could be concerned in early B cell triggering 
to TD and TI-2 antigen.  However, the former interpretation  is strongly favored by 
the  finding  that  M~  factor competitively inhibits  the  action  of Ly-5  antibody  in 
reducing  PFC  generation  to  SRBC,  and  that  PFC  inhibition  by  Ly-5  antibody 
appears to be inseparable from the time of action of Mq~ factor. 
Summary 
Generation of anti-sheep erythrocyte plaque-forming ceils (PFC)  is greatly reduced 
in the presence of monoclonal Ly-5 alloantibody. Although  Ly-5 is expressed in one YAKURA,  SHEN,  BOURCET,  AND BOYSE  1087 
of its molecular forms on T  cells and macrophages (M4,) involved in this response, the 
only demonstrated action of Ly-5 antibody was on B cells. Evidence from elimination 
of Lyt-2  + cells, and from the responses of serial proportions of Ly-5.1 and Ly-5.2 cells 
and of Ly-5 heterozygous cells, signifies that PFC reduction cannot be ascribed to any 
known mechanism of suppression  or to a  direct suppressive  action of Ly-5 antibody 
on B  cells.  A  critical  distinction  of Ly-5 from Lyb-2 is  that  Ly-5 antibody reduces 
PFC  generation  to trinitrophenylated  Ficoll,  a  thymus-independent  type  2  antigen 
requiring T  cells and M4~ for maximal  PFC generation in vitro. A  second distinction 
is that PFC reduction by Ly-5 antibody is strictly tied to the time of operation of M~ 
factor,  whereas  PFC  reduction  by  Lyb-2  antibody  relates  to  the  time  of B  cell 
triggering  by  antigen.  Accordingly,  M4~  factor  competitively  and  quantitatively 
inhibits  the action of Ly-5 antibody in reducing PFC generation.  It is likely that the 
Ly-5 system is concerned in the reception or handling of M4~ message by B cells. 
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